Vincenzo B Polsinelli1, Arjun Sinha1, Sanjiv J Shah2. 1. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 2. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. sanjiv.shah@northwestern.edu.
Abstract
PURPOSE OF REVIEW: Visceral venous congestion of the gut may play a key role in the pathogenesis of right-sided heart failure (HF) and cardiorenal syndromes. Here, we review the role of right ventricular (RV) dysfunction, visceral congestion, splanchnic hemodynamics, and the intestinal microenvironment in the setting of right-sided HF. We review recent literature on this topic, outline possible mechanisms of disease pathogenesis, and discuss potential therapeutics. RECENT FINDINGS: There are several mechanisms linking RV-gut interactions via visceral venous congestion which could result in (1) hypoxia and acidosis in enterocytes, which may lead to enhanced sodium-hydrogen exchanger 3 (NHE3) expression with increased sodium and fluid retention; (2) decreased luminal pH in the intestines, which could lead to alteration of the gut microbiome which could increase gut permeability and inflammation; (3) alteration of renal hemodynamics with triggering of the cardiorenal syndrome; and (4) altered phosphate metabolism resulting in increased pulmonary artery stiffening, thereby increasing RV afterload. A wide variety of therapeutic interventions that act on the RV, pulmonary vasculature, intestinal microenvironment, and the kidney could alter these pathways and should be tested in patients with right-sided HF. The RV-gut axis is an important aspect of HF pathogenesis that deserves more attention. Modulation of the pathways interconnecting the right heart, visceral congestion, and the intestinal microenvironment could be a novel avenue of intervention for right-sided HF.
PURPOSE OF REVIEW: Visceral venous congestion of the gut may play a key role in the pathogenesis of right-sided heart failure (HF) and cardiorenal syndromes. Here, we review the role of right ventricular (RV) dysfunction, visceral congestion, splanchnic hemodynamics, and the intestinal microenvironment in the setting of right-sided HF. We review recent literature on this topic, outline possible mechanisms of disease pathogenesis, and discuss potential therapeutics. RECENT FINDINGS: There are several mechanisms linking RV-gut interactions via visceral venous congestion which could result in (1) hypoxia and acidosis in enterocytes, which may lead to enhanced sodium-hydrogen exchanger 3 (NHE3) expression with increased sodium and fluid retention; (2) decreased luminal pH in the intestines, which could lead to alteration of the gut microbiome which could increase gut permeability and inflammation; (3) alteration of renal hemodynamics with triggering of the cardiorenal syndrome; and (4) altered phosphate metabolism resulting in increased pulmonary artery stiffening, thereby increasing RV afterload. A wide variety of therapeutic interventions that act on the RV, pulmonary vasculature, intestinal microenvironment, and the kidney could alter these pathways and should be tested in patients with right-sided HF. The RV-gut axis is an important aspect of HF pathogenesis that deserves more attention. Modulation of the pathways interconnecting the right heart, visceral congestion, and the intestinal microenvironment could be a novel avenue of intervention for right-sided HF.
Authors: W H Wilson Tang; Zeneng Wang; Yiying Fan; Bruce Levison; Jennie E Hazen; Lillian M Donahue; Yuping Wu; Stanley L Hazen Journal: J Am Coll Cardiol Date: 2014-10-27 Impact factor: 24.094
Authors: J Vlachogiannakos; A S Saveriadis; N Viazis; I Theodoropoulos; K Foudoulis; S Manolakopoulos; S Raptis; D G Karamanolis Journal: Aliment Pharmacol Ther Date: 2009-02-07 Impact factor: 8.171
Authors: Gerhard Poelzl; Michael Ess; Andreas Von der Heidt; Michael Rudnicki; Matthias Frick; Hanno Ulmer Journal: Eur J Intern Med Date: 2012-12-23 Impact factor: 4.487
Authors: Andrew G Spencer; Eric D Labonte; David P Rosenbaum; Craig F Plato; Christopher W Carreras; Michael R Leadbetter; Kenji Kozuka; Jill Kohler; Samantha Koo-McCoy; Limin He; Noah Bell; Jocelyn Tabora; Kristin M Joly; Marc Navre; Jeffrey W Jacobs; Dominique Charmot Journal: Sci Transl Med Date: 2014-03-12 Impact factor: 17.956
Authors: Chelsea L Organ; Hiroyuki Otsuka; Shashi Bhushan; Zeneng Wang; Jessica Bradley; Rishi Trivedi; David J Polhemus; W H Wilson Tang; Yuping Wu; Stanley L Hazen; David J Lefer Journal: Circ Heart Fail Date: 2015-12-23 Impact factor: 8.790
Authors: Navin K Kapur; Richard H Karas; Sarah Newman; Lena Jorde; Tina Chabrashvili; Shiva Annamalai; Michele Esposito; Carey D Kimmelstiel; Tim Lenihan; Daniel Burkhoff Journal: Catheter Cardiovasc Interv Date: 2019-05-21 Impact factor: 2.692
Authors: Navin K Kapur; Lara Reyelt; Paige Crowley; Lauren Richey; John McCarthy; Shiva Annamalai; Sarah Newman; Lena Jorde; Sina Forotuanjazi; Allen Razavi; Tim Lenihan; Daniel Burkhoff; Richard H Karas Journal: J Cardiovasc Transl Res Date: 2019-11-26 Impact factor: 4.132
Authors: Antonella Gallo; Noemi Macerola; Angela Maria Favuzzi; Maria Anna Nicolazzi; Antonio Gasbarrini; Massimo Montalto Journal: Med Princ Pract Date: 2022-01-28 Impact factor: 2.132